Clin2
NCT06243588Possibly a fitRecruiting

Looking back at Ewing sarcoma treatments to guide future care

Ewing Sarcoma

Part of Cancer clinical trials.

This study looks at past patient records to understand what factors affect outcomes and how radiation therapy (high-energy beams to kill cancer cells) helps people with Ewing sarcoma. If you were treated for this bone cancer in the past, your data could help improve treatment for others.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
400 people
Ages
2 years and older
Study type
Observational

Who can take part

  • You were treated for Ewing sarcoma between 1991 and 2021 at the Rizzoli Orthopaedic Institute.
  • You are at least 2 years old.
  • You had a confirmed diagnosis of Ewing sarcoma.
  • Your medical records and imaging scans (like X-rays or MRIs) are available.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07188532Recruiting
Personalized high-dose radiation for Ewing sarcoma

This trial tests a personalized radiation therapy that adjusts the dose based on your tumor. It aims to improve treatment for Ewing sarcoma while limiting side effects.

Phoenix, Arizona
NCT07620431Not yet recruiting
Radiation before surgery for Ewing sarcoma

This trial tests giving radiation therapy before surgery to treat Ewing sarcoma, a bone cancer that's hard to remove completely. The goal is to shrink the tumor first, then remove it surgically, to improve outcomes for patients with high-risk disease.

Beijing
NCT07725783Recruiting
Blood test monitoring for Ewing sarcoma treatment

This study is testing whether a blood test called ProGRP can help doctors see how well treatment is working in people with Ewing sarcoma. If you are newly diagnosed and are about to start your first treatment, this study may help improve how we track your progress.

Beijing
NCT07781891Not yet recruiting· Phase 2
New drug testing for relapsed Ewing sarcoma

This trial tests new drugs for young people with Ewing sarcoma or similar sarcomas that have come back or not responded to standard treatment. The goal is to see if these drugs can shrink or control the cancer.

Houston, Texas
NCT06564272Recruiting· Phase 2
Study of KC1036 for teens with advanced Ewing sarcoma

This trial tests an experimental drug, KC1036, for adolescents with advanced Ewing sarcoma that has not responded to other treatments. It aims to see if the drug can help shrink tumors or slow the cancer.

Beijing, Beijing Municipality
NCT06796543Recruiting
Radiation for young patients with sarcoma that has spread

This trial tests whether targeted radiation can help children and young adults with sarcoma that has spread to a few spots in the body. It's for those who are newly diagnosed (Stratum A) or whose sarcoma has come back or worsened (Stratum B).

Washington D.C., District of Columbia

Hear when a new Ewing Sarcoma trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.